Authors

• Joseph C. Van Amburg (ORCID: https://orcid.org/0000-0002-1410-6995)
• P. Brent Ferrell (ORCID: https://orcid.org/0000-0003-1140-9154)
• Alexander G. Bick (ORCID: https://orcid.org/0000-0001-5824-9595)
• Christopher J. Farady (ORCID: https://orcid.org/0000-0002-3607-9721)
• Yash Pershad (ORCID: https://orcid.org/0000-0002-2282-1403)
• J. Brett Heimlich (ORCID: https://orcid.org/0000-0003-2812-5326)
• Alyssa Parker (ORCID: https://orcid.org/0000-0002-6632-7458)
• Michael Mendelson (ORCID: https://orcid.org/0000-0001-7590-3958)
• Philipp J. Rauch (ORCID: https://orcid.org/0000-0001-8677-0986)
• David E. Ong (ORCID: https://orcid.org/0009-0000-4260-6762)
• Ketan J Hoey

Institutions

• Novartis (Switzerland) (CH)
• Vanderbilt University (US)
• Vanderbilt University Medical Center (US)

Publication Details

Journal

Blood Advances

Published

2025-10-31

DOI

https://doi.org/10.1182/bloodadvances.2025017293

Primary Topic

Cancer Genomics and Diagnostics

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Alexander and Margaret Stewart Trust
• National Institutes of Health